Stanford researchers have developed an AI-powered "virtual scientist" capable of designing drug and vaccine candidates, marking a leap forward in biomedical research.
UK based scientists witnessed how COVID-19 can mutate in a highly vulnerable patient, even when that person is undergoing convalescent plasma treatment.
Recent data published by the UK’s independent medicines regulator assures the Pfizer/BioNTech and the Oxford University/AstraZeneca vaccines meet strict regulatory standards for safety
The government has confirmed that from the 15th of February travellers entering the UK from a country on the travel ban list will be required to quarantine in a government-approved hotel.
A new study from Umeå University and Karolinska Institutet has found that people with severe mental disorders have a significantly increased risk of dying from COVID-19.
Paul Barrett, TeleTracking UK, explains how automating patient flow and bed management in real-time can transform hospital operations, free up time for nurses to care, reduce stress on caregivers and importantly improve patient outcomes.
Israel has agreed to give the first 5,000 vaccine doses to Palestinian medical workers - but only if they live in annexed east Jerusalem, while the West Bank and Gaza remain without vaccines.
AstraZeneca dose efficiency holds at 76% in the three-month period between the first and second dose - suggesting that this time period is good for maximising protection.
Jade Brooks, an associate solicitor at Blaser Mills Law, responds to The Supreme Court’s ruling on coronavirus-related business interruption insurance claims and discusses what it means for policyholders.
According to data collected by 400 healthcare professionals at the worst moment of the US outbreak, the life support machine that acts in place of the heart and lungs is crucial to reducing COVID-19 deaths for the critically ill.
